Navigation Links
LEVEL Life's "FUEL A Cure" Diabetes Contest
Date:11/14/2012

DENVER, Nov. 14, 2012 /PRNewswire-iReach/ -- To celebrate World Diabetes Day, LEVEL Foods LLC is launching a nationwide contest to find their next LEVEL Life glucose gel flavor. This diabetes nutrition business has committed to donate $1 of every sale from their "Fuel A CURE" Glucose Gels back to the American Diabetes Association (ADA) and Juvenile Diabetes Research Foundation (JDRF).

(Photo: http://photos.prnewswire.com/prnh/20121114/CG13504)

At LEVEL Life, they believe in making great products to support people living with diabetes. They are committed, in the mission of the ADA and JDRF to find a cure for diabetes.  Founder, Ethan Lewis says   "We've combined these two passions — a great product fueling important research — in our new 'Let's Fuel a Cure' Contest. It's a great way to get the community involved in raising diabetes awareness."

LEVEL Life's "Fuel A Cure" Contest will run through February 13, 2013 and will let consumers choose the company's next Glucose Gel flavor. LEVEL Life fan's can visit the company's Facebook page to submit their new flavor idea and story of how diabetes has inspired them to live life to the fullest.

However, it's no ordinary flavor, $1 from each sale of the newly created and community inspired product will be donated to support diabetes research. The winner of the contest will receive Free LEVEL Life Glucose Gel for one year — and have their name and inspiring story featured on every LEVEL Life "Fuel A CURE" package!  

To enter the contest, visit: http://www.facebook.com/LevelFoods/app_95936962634

LEVEL Foods LLC is committed to giving back to the diabetes community in an effort to raise awareness and help fund a cure for the disease which affects more than 26 million people in the US alone. 

For further details about "LEVEL Life "Fuel A Cure Contest and official contest rules, please go to http://www.facebook.com/LevelFoods/app_95936962634

About Level Foods, LLC.

The U.S. diabetes, obese and overweight population have historically outpaced population growth. There are currently 26 million people living with diabetes in the U.S (2x increase in last 10 years) and another 80 million people identified with pre-diabetes.  Diabetes is worldwide. As of 2008, there were over 347 million people living with Type 1 and Type 2 diabetes and the growth of the disease has accelerated tremendously in the last few years.  Level Life is a key player in this growing epidemic, and offers a powerful lifetime approach to diabetes management. Level Life products focus on the blood sugar management and healthy lifestyle. Backed by research and consumer success stories, these products allow people to keep moving forward.

Media Contact: Jennifer McGhee Level Foods, 303-520-2595, Jennifer@LevelFoods.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Level Foods
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Phase 3 Results Show Canagliflozin as Add-On Therapy to Metformin and Pioglitazone Significantly Lowers Blood Sugar Levels in Adult Patients with Type 2 Diabetes
2. Medical Marijuana Inc. in a Strong Market Position with Amendment 64 in Colorado, Initiative 502 in Washington and the Pending Ninth District Decision Regarding the Schedule 1 Status of Medical Marijuana on a Federal Level
3. Cleveland Clinic and IBM Work to Advance Watsons Use in the Medical Training Field
4. Parker Creates Endowed Chair at Cleveland State University for Research in Human Motion and Control
5. Medical Alarm Provides Investor Update -- Company Surpassing Previous Record Order Levels as Consumer Interest Accelerates
6. Cleveland Clinics 2012 Medical Innovation Summit Highlights Orthopaedic Technologies
7. Nouveau Life Pharmaceuticals (NOUV) Releases Krill Oil to Support Healthy Cholesterol Levels and Reduce Inflammation
8. Misonix Participates In Cleveland Spine Review
9. Cleveland Clinic Lou Ruvo Center for Brain Health and MedAvante Announce Alliance
10. NABP Applies for New .PHARMACY Generic Top-Level Domain to Provide a Secure Destination for Consumers
11. Denton Vacuum Ships Breakthrough Wafer-level Optics Development System to Leading German R&D Organization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
Breaking Medicine News(10 mins):